NL-OMON34715已完成不适用
An open-label, randomized crossover study to evaluate the effect of ASP1941 on the pharmacokinetics, pharmacodynamics, safety and tolerability of glimepiride in healthy subjects and vice versa. - study drug/glimepiride interaction study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Between 18 and 55 years of age
- •- BMI between 18.5 and 30.0 kg/m2
- •- Not a heavy smoker
排除标准
- •An important medical disorder, hepatitis B, cancer or HIV/AIDS detected during screening.
研究者
相似试验
已完成
不适用
An open-label, randomized crossover study to evaluate the pharmacokinetics, bioavailability, bioequivalence, and food effect following administration of Oxybate Formulations in healthy subjects.NL-OMON41817Jazz Pharmaceuticals60
已完成
不适用
A randomized, open-label, crossover study to evaluate ICS/LABA treatment versus LAMA/LABA treatment in COPD with eosinophilic inflammatioCOPDJPRN-UMIN000024905Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital25
已完成
3 期
An open-label randomised cross-over study to evaluate the albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetes10012653Diabetes MellitusdiabetesNL-OMON46820Martini Ziekenhuis20
进行中（未招募）
1 期
Study to evaluate the effect of dapagliflozin, exenatide and their combination on the loss of protein in urine in patients with type 2 diabetesEUCTR2017-004709-42-NLMartini Hospital17
尚未招募
不适用
An open-label randomised cross-over study to evaluate the albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetesDiabetes Mellitus Type 2 (DM type II), AlbuminuriaNL-OMON24855niversity Medical Center Groningen (UMCG)17